CUBTOTCHealthcare · Biotechnology

Curative Biotechnology, Inc.

$1.49-8.90%($-0.14)

TickerSpark Score

45/100

Weak

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CUBT research report →

52-Week Range64% of range

Low $0.59

Current $1.49

High $1.99

Companycurativebiotech.com

Curative Biotechnology, Inc. operates as a development-stage biomedical company. The company develops pipeline focusing on therapeutic areas, such as infectious diseases, oncology, and degenerative eye disease.

CEO: I. Richard Garr
IPO: 1998
Employees: 4
HQ: Palm Beach Gardens, FL, US

Price Chart

-6.94% · this period

Valuation

Market Cap: $10.62M
P/E: -6.66
P/S: 0.00
P/B: -1.85
EV/EBITDA: -14.86
Div Yield: 0.00%

Profitability

Gross Margin: 0.00%
Op Margin: 0.00%
Net Margin: 0.00%
ROE: 27.96%
ROIC: 50.65%

Growth & Income

Revenue: $0 · 0.00%
Net Income: $-2,263,073 · 36.52%
EPS: $-0.00 · 99.50%
Op Income: $-1,502,061
FCF YoY: 15.04%

Performance & Tape

52W High: $1.99
52W Low: $0.59
50D MA: $1.19
200D MA: $1.19
Beta: 1.16
Avg Volume: 2.92K

Get TickerSpark's AI analysis on CUBT

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime